Maravai LifeSciences Holdings Inc (MRVI): A Case For Going Higher

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.

Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Maravai LifeSciences Holdings Inc is $569.71M. A total of 4.73 million shares were traded on the day, compared to an average of 3.09M shares.

In the most recent transaction, ORESHACK KURT sold 25,000 shares of MRVI for 5.03 per share on Jan 31 ’25. After the transaction, the General Counsel now owns 167,618 company shares. In a previous transaction on Jan 31 ’25, ORESHACK KURT bought 25,000 shares at 5.03 per share.

Among the insiders who bought shares, DeFord John A acquired of 17,500 shares on Nov 12 ’24 at a per-share price of $5.75. This resulted in the Director holding 70,046 shares of MRVI after the transaction. In another insider transaction, HULL CARL bought 175,000 shares at $5.64 per share on Nov 11 ’24. Company shares held by the insider now total 175,000.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, MRVI has a high of $11.56 and a low of $2.07.

As of this writing, MRVI has an earnings estimate of -$0.07 per share for the current quarter. EPS was calculated based on a consensus of 14.0 estimates, with a high estimate of -$0.04 per share and a lower estimate of -$0.11.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. MRVI’s latest balance sheet shows that the firm has $551.27M in Cash & Short Term Investments as of fiscal 2021. There were $575.22M in debt and $93.78M in liabilities at the time. Its Book Value Per Share was $2.29, while its Total Shareholder’s Equity was $545.36M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MRVI is Buy with a score of 3.73.

Most Popular

Related Posts